Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2051-1426

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study ; volume:7 ; number:1 ; day:22 ; month:5 ; year:2019 ; pages:1-9 ; date:12.2019
Journal for ImmunoTherapy of Cancer ; 7, Heft 1 (22.5.2019), 1-9, 12.2019

Creator: Johnson, Douglas B.
Manouchehri, Ali
Haugh, Alexandra M.
Quach, Henry T.
Balko, Justin M.
Lebrun-Vignes, Benedicte
Mammen, Andrew
Moslehi, Javid J.
Salem, Joe-Elie

Contributor: SpringerLink (Online service)

DOI: 10.1186/s40425-019-0617-x

URN: urn:nbn:de:101:1-2019110822275639382063

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:30 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Johnson, Douglas B.
Manouchehri, Ali
Haugh, Alexandra M.
Quach, Henry T.
Balko, Justin M.
Lebrun-Vignes, Benedicte
Mammen, Andrew
Moslehi, Javid J.
Salem, Joe-Elie
SpringerLink (Online service)

Other Objects (12)

Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity

Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database

Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor

Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians

Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity

Risk factors of immune checkpoint inhibitor-associated acute kidney injury: evidence from clinical studies and FDA pharmacovigilance database

Adverse reactions of immune checkpoint inhibitors combined with Proton pump inhibitors: a pharmacovigilance analysis of drug-drug interactions

IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma

Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy

Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity

Hochschulschrift

A toxicogenomic- and pharmacovigilance-based evaluation of drug-induced liver toxicity

Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity

Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database

Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor

Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians

Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity

Risk factors of immune checkpoint inhibitor-associated acute kidney injury: evidence from clinical studies and FDA pharmacovigilance database

Adverse reactions of immune checkpoint inhibitors combined with Proton pump inhibitors: a pharmacovigilance analysis of drug-drug interactions

IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma

Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy

Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity

Hochschulschrift

A toxicogenomic- and pharmacovigilance-based evaluation of drug-induced liver toxicity

Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity

Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database

Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor

Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians

Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity

Risk factors of immune checkpoint inhibitor-associated acute kidney injury: evidence from clinical studies and FDA pharmacovigilance database

Adverse reactions of immune checkpoint inhibitors combined with Proton pump inhibitors: a pharmacovigilance analysis of drug-drug interactions

IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma

Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy

Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity

Hochschulschrift

A toxicogenomic- and pharmacovigilance-based evaluation of drug-induced liver toxicity

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity

Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database

Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor

Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians

Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity

Risk factors of immune checkpoint inhibitor-associated acute kidney injury: evidence from clinical studies and FDA pharmacovigilance database

Adverse reactions of immune checkpoint inhibitors combined with Proton pump inhibitors: a pharmacovigilance analysis of drug-drug interactions

IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma

Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy

Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity

A toxicogenomic- and pharmacovigilance-based evaluation of drug-induced liver toxicity

Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity

Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database

Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor

Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians

Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity

Risk factors of immune checkpoint inhibitor-associated acute kidney injury: evidence from clinical studies and FDA pharmacovigilance database

Adverse reactions of immune checkpoint inhibitors combined with Proton pump inhibitors: a pharmacovigilance analysis of drug-drug interactions

IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma

Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy

Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity

A toxicogenomic- and pharmacovigilance-based evaluation of drug-induced liver toxicity

Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity

Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database

Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor

Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians

Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity

Risk factors of immune checkpoint inhibitor-associated acute kidney injury: evidence from clinical studies and FDA pharmacovigilance database

Adverse reactions of immune checkpoint inhibitors combined with Proton pump inhibitors: a pharmacovigilance analysis of drug-drug interactions

IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma

Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy

Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity

A toxicogenomic- and pharmacovigilance-based evaluation of drug-induced liver toxicity

Related objects

Reset password